Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Is blasting into a river bluff any way to do palaeontology? Alison Abbott reports on an unusual expedition into the Alaskan wilderness in search of the bones of polar dinosaurs.
M. S. Swaminathan transformed agriculture in India in the 1960s. Now Daemon Fairless finds him at the heart of another high-tech scheme to help the rural poor.
Under the rubble of war-torn Afghanistan lie natural resources worth billions. Rex Dalton reports from Kabul on the scientists risking their lives to see them developed for the good of the country.
The nitrogen cycle rarely features in the grim litany of things at risk from global warming. Nick Lane reports on research that might change this ? with grave consequences for ocean chemistry.
Despite a training in clinical genetics, Hugh Rienhoff didn't know what was wrong with his daughter. So, as he tells Brendan Maher, he set about finding out.
How do nuclear inspectors know when all is not as they are told? Geoff Brumfiel joins some inspectors-in-training as they learn the ropes at the Los Alamos National Laboratory.
India, like many countries, has high hopes for jatropha as a biofuel source, but little is known about how to make it a successful crop. Daemon Fairless digs for the roots of a new enthusiasm.
Russian researchers, and those who have worked in Russia, share their thoughts with Nature on the problems faced by the country's scientific system ? and how they could be addressed.
International collaboration and a can-do spirit have allowed some Russian scientists to flourish. Alison Abbott watches an extraordinary field test for mutant mice in the Russian wilderness.
The Russian Academy of Sciences has resisted pressure from czarists and communists. Can it thwart the reforms planned by Putin's government? Quirin Schiermeier reports.
Can a stage spectacular based on a TV documentary bring science to life and please the punters too? Brendan Maher joins a palaeontologist to watch the dinosaurs walk.
As several lucrative protein-based drugs are poised to go off patent, makers of biopharmaceuticals argue that their products are too complex to be reproduced as generics. Heidi Ledford investigates how close 'biosimilar' drugs can get to the original.
The world's biggest, best-equipped research drilling vessel is about to set off on its first scientific voyage. David Cyranoski previews its quest to catch a formidable earthquake in the act.
Particle accelerators that use plasma technology promise to shake up the fields of high-energy particle physics and cancer treatment. Challenges remain, but smaller, cheaper machines are within reach. Navroz Patel reports.
Above ground, plants compete for life-giving sunlight, but below the surface a more complex picture emerges. John Whitfield explores the role of mycorrhizae in plant ecology.
The whole world felt the effects of the dinosaur-killing mass extinction 65 million years ago. But a spot in Colorado may have the best record of it. Rex Dalton reports from Denver.
Dubious science and looming legalization of the tiger trade threaten to derail China's efforts to save the Siberian tiger. Jerry Guo goes to the world's largest tiger-breeding facility to investigate.
Physicists interested in the mechanics of single molecules are helping open one of the blackest boxes in biology. Brendan Maher discovers how the disciplines are working together.
When it was trying to catapult satellites into orbit the private launch business didn't get very far. Can it do better now that it's focused on giving the rich the ride of their life, asks David Chandler.
